Aybike Birerdinc, Ph.D.
Affiliations: | 2008 | George Mason University, Washington, DC |
Area:
Genetics, Cell Biology, Molecular BiologyGoogle:
"Aybike Birerdinc"Parents
Sign in to add mentorAncha Baranova | grad student | 2008 | George Mason | |
(Role of KCNRG in B-cell chronic lymphocytic leukemia.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Estep JM, de Avila L, Weinstein AA, et al. (2020) Tu1659 DYSREGULATION OF INSULIN-LIKE GROWTH FACTOR 1 (IGF1), IGF BINDING PROTEIN 3 (IGFBP3), AND ALPHA-1-ACID GLYCOPROTEIN (AGP) IN NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) Gastroenterology. 158: S-1442 |
Estep JM, Price JK, de Avila L, et al. (2020) Su1633 HUMAN ACTIVITY PROFILE IN THE CONTEXT OF NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND TYPE II DIABETES MELLITUS (DM) Gastroenterology. 158: S-1365-S-1366 |
Weinstein AA, Estep JM, de Avila L, et al. (2019) Relationships among neurotransmitters, cytokines and cognitive performance for individuals with hepatitis C achieving sustained virologic response: A pilot study. Journal of Neuroimmunology. 335: 577022 |
de Avila L, Weinstein AA, Estep JM, et al. (2019) Cytokine Balance is Restored as Patient Reported Outcomes (PROs) Improve in Patients Recovering from Chronic Hepatitis C (CHC). Liver International : Official Journal of the International Association For the Study of the Liver |
Birerdinc A, Younossi ZM. (2018) Epigenome-Wide Association Studies Provide Insight into the Pathogenesis of Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis. Annals of Hepatology. 17: 11-13 |
Younossi ZM, Karrar A, Pierobon M, et al. (2018) An exploratory study examining how nano-liquid chromatography-mass spectrometry and phosphoproteomics can differentiate patients with advanced fibrosis and higher percentage collagen in non-alcoholic fatty liver disease. Bmc Medicine. 16: 170 |
Birerdinc A, Stoddard S, Younossi ZM. (2018) The Stomach as an Endocrine Organ: Expression of Key Modulatory Genes and Their Contribution to Obesity and Non-alcoholic Fatty Liver Disease (NAFLD). Current Gastroenterology Reports. 20: 24 |
Deavila L, Weinstein A, Curry M, et al. (2018) Changes in serum neurotransmitters are associated with changes in patient reported outcomes and neurocognitive performance in patients with hepatitis C virus-genotype 1 who achieved sustained virologic response Journal of Hepatology. 68: S311-S312 |
Stoddard S, Kurzke K, Monge F, et al. (2018) Tu1546 - Liver Fibrosis as Assessed by Percent Collagen Deposition by Morphometry Shows an Inverse Correlation to Both IL-7 and INF-G in Obese Non-Alcoholic Liver Disease (NAFLD) Patients Gastroenterology. 154: S-1247 |
Estep JM, Mehta R, Felix SC, et al. (2018) Sa1471 - Integrin Beta 3 Subunit Leu48->Pro Polymorphism is Positively Associated with Pericellular Fibrosis in Non-Alcoholic Fatty Liver Disease (NAFLD) Gastroenterology. 154: S-1124 |